Drug target · DRD2

D2

Dopamine D2 receptor

1 compound in the CNS pipeline acts on D2.

Compounds targeting D2

CompoundActionAffinityLead programDeveloper
Rotigotine extended-release microspheres (LY03003)Small moleculeAgonistKi 13.5 nMApprovedParkinson's diseaseLuye Pharma Group Ltd.